Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.

Manuela SchmidtYou-Shan FengSven SchnichelsTarek BayyoudMarius UeffingKarl Ulrich Bartz-SchmidtPeter MartusAndreas Peter

Published in: BMJ open ophthalmology (2021)

The great demand and acceptance confirmed the benefit of highly sensitive testing methods in the early phase of the pandemic. The coincidence of low seroprevalence and anxious employees may have contributed to internalising the need of hygiene measures.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
mental health
molecularly imprinted
living cells
fluorescent probe
high resolution
single molecule